Maven Securities LTD Cardiff Oncology, Inc. Transaction History

Maven Securities LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$6.65 - $10.04 $36,468 - $55,059	-5,484 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$9.1 - $19.57 $49,904 - $107,321	5,484 New	5,484 $51,000
Q4 2020 Feb 12, 2021	SELL	$12.02 - $24.71 $721,200 - $1.48 Million	-60,000 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$4.25 - $14.19 $255,000 - $851,400	60,000 New	60,000 $853,000

12.3M

813K

91.1K

Ticker CRDF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,334,900
Market Cap $185M
Description
Cardiff Oncology, Inc., a clinical-stage oncology company, develops medicine treatment for cancer patients in California. Its lead drug candidate is onvansertib, an oral selective Polo-like Kinase 1 Inhibitor for anti-cancer therapeutics; CY140, an inhibitor of PLK1, PLK2, and PLK3 that is in phase 1/2 studies in solid tumors and leukemias; meta...

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

Stay updated on Maven Securities LTD with notifications on news.